electronRx launches smartphone-based lung monitoring through digital biomarkers
Medical technology company electronRx has developed a smartphone-based system for monitoring lung function in patients with chronic respiratory diseases (CRDs). The purpleDx app, which will launch at CES 2025 in Las Vegas, transforms mobile phones into diagnostic tools by capturing and analysing digital biomarkers through the device’s camera.
